Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2019-07-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-004698
Form type
SC 13G
Filer
CAXTON CORP
CIK
CIK 1388551
Filed
Jul 19, 2019
Reporting period
Jul 11, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub